PrimeRFP SCOUT · Federal Contract Recompete Brief

75N95025P00418Subject MATTER EXPERT consultant for DRUG — Pearson Pharma Partners

Pearson Pharma Partners holds $276K across 2 federal awards, concentrated at Department of Health and Human Services (HHS). Competition previously drew 4 offers. Set-aside status: SBA. Recompete timing centers on the Sep 17, 2027 PoP end — agencies typically plan 12–18 months ahead.

National Institutes Of Health Nida

Awarding office

Pearson Pharma Partners

Recipient

Sep 17, 2027

PoP end

$98K

Obligated

$184K

Potential

541990

NAICS

R499

PSC

SBA

Set-aside

4 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Pearson Pharma Partners — $90

Contract facts

SBA

Contract number75N95025P00418

AgencyNational Institutes Of Health Nida

Awarding officeNational Institutes Of Health Nida

Awarding agencyDepartment of Health and Human Services (HHS)

Funding agencyDepartment of Health and Human Services (HHS)

IncumbentPearson Pharma Partners

CAGE6EHY7

UEITJN3M3UNJF15

NAICS541990

No full NAICS 541990 intel page yet. Browse NAICS intelligence

PSCR499

Place of performanceWESTLAKE VILLAGE CA

Pricing typeLabor Hours

Extent competedCompeted Under SAP

Related solicitation75N95025Q00250

PoP startSep 18, 2025

PoP end (current)Sep 17, 2027

Obligated$98K

Current value$184K

Potential value$184K

SUBJECT MATTER EXPERT CONSULTANT FOR DRUG METABOLISM PHARMACOKINETICS [DMPK]. is a federal SBA award for National Institutes Of Health Nida held by Pearson Pharma Partners. Estimated value $184K ($98K obligated). Current period of performance ends Sep 17, 2027. Last award drew 4 bidders. Place of performance: WESTLAKE VILLAGE CA. Related solicitation 75N95025Q00250.

SUBJECT MATTER EXPERT CONSULTANT FOR DRUG METABOLISM PHARMACOKINETICS [DMPK].

Recompete timing

Public

● Expiring in 371 days

Current PoP ends Sep 17, 2027 (371 days remaining). Agencies typically plan 12–18 months ahead — position before the PoP clock runs out.

Incumbent footprint

Public record

Pearson Pharma Partners — $276K obligated across 2 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)

Department of Health and Human Services (HHS)$276K · 100% of firm total

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75N95025P00418?

75N95025P00418 (Subject MATTER EXPERT consultant for DRUG) is a National Institutes Of Health Nida award with a potential value of $184K, currently held by Pearson Pharma Partners. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75N95025P00418?

National Institutes Of Health Nida awarded 75N95025P00418 to Pearson Pharma Partners (potential $184K).

Who is the incumbent on 75N95025P00418?

Pearson Pharma Partners is the incumbent with $276K across 2 related awards in SCOUT’s public footprint. The current period of performance ends Sep 17, 2027.

When does Pearson Pharma Partners’s 75N95025P00418 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 17, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on 75N95025P00418 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 1, 2026 · refreshed monthlyLatest procurement action Aug 31, 2026